Portfolio Holdings Detail for ISIN IE000T9EOCL3
Stock Name / FundiShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)
Issuer
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerEWSA(USD) Euronext Amsterdam

Holdings detail for FLGT

Stock NameFulgent Genetics Inc
TickerFLGT(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS3596641098
LEI549300CL6P01M68QJ404

Show aggregate FLGT holdings

News associated with FLGT

Federated Hermes Inc. Boosts Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 11.0% during the 1st quarter, HoldingsChannel reports. The fund owned 46,479 shares of the company’s stock after acquiring an additional 4,597 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $785,000 at the end […] - 2025-08-08 05:10:53
Fulgent Genetics (NASDAQ:FLGT) Upgraded to “Buy” at UBS Group
UBS Group upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a neutral rating to a buy rating in a report published on Tuesday, Marketbeat reports. The firm currently has $30.00 price objective on the stock, up from their prior price objective of $20.00. A number of other brokerages also recently issued reports on […] - 2025-08-06 04:38:58
Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price
Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its target price lowered by analysts at Piper Sandler from $23.00 to $21.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 1.06% from […] - 2025-08-06 02:52:55
Fulgent Genetics (NASDAQ:FLGT) Shares Down 3.4% After Analyst Downgrade
Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report)’s share price dropped 3.4% on Monday after Piper Sandler lowered their price target on the stock from $23.00 to $21.00. Piper Sandler currently has a neutral rating on the stock. Fulgent Genetics traded as low as $17.92 and last traded at $17.90. Approximately 59,010 shares were traded […] - 2025-08-06 02:13:03
Fulgent Genetics (NASDAQ:FLGT) & Outset Medical (NASDAQ:OM) Head-To-Head Analysis
Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations and institutional ownership. Institutional and Insider Ownership 48.1% of Fulgent […] - 2025-07-23 04:07:07
Alps Advisors Inc. Sells 1,980 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
Alps Advisors Inc. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 8.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,752 shares of the company’s stock after selling 1,980 shares during the period. Alps […] - 2025-07-16 05:23:11
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,654 shares of the company’s stock after […] - 2025-06-11 04:36:52
Two Sigma Investments LP Reduces Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Two Sigma Investments LP cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 80,082 shares of the company’s stock after selling 2,749 shares during the period. Two Sigma Investments LP’s […] - 2025-06-04 05:08:51
Squarepoint Ops LLC Grows Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Squarepoint Ops LLC boosted its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 178.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,608 shares of the company’s stock after buying an additional 26,659 shares during the quarter. Squarepoint Ops LLC owned […] - 2025-06-03 05:04:50
State of Wyoming Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
State of Wyoming bought a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,109 shares of the company’s stock, valued at approximately $57,000. Several other hedge funds and other institutional investors […] - 2025-05-29 04:47:02
Quantinno Capital Management LP Makes New Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Quantinno Capital Management LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 13,079 shares of the company’s stock, valued at approximately $242,000. Several other large investors have also recently added to or reduced their stakes in the company. Millennium […] - 2025-05-27 04:56:53
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $987,000 Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 53,413 shares of the company’s stock after selling 2,800 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Fulgent Genetics were […] - 2025-05-26 04:43:01
Deutsche Bank AG Has $2.43 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Deutsche Bank AG raised its position in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 6.1% during the fourth quarter, Holdings Channel reports. The firm owned 131,430 shares of the company’s stock after purchasing an additional 7,532 shares during the period. Deutsche Bank AG’s holdings in Fulgent Genetics were worth $2,428,000 at the end of […] - 2025-05-22 05:36:54
Balyasny Asset Management L.P. Buys Shares of 26,313 Fulgent Genetics, Inc. (NASDAQ:FLGT)
Balyasny Asset Management L.P. bought a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 26,313 shares of the company’s stock, valued at approximately $486,000. Balyasny Asset Management L.P. owned 0.09% of […] - 2025-05-16 05:50:59
Comparing Fulgent Genetics (NASDAQ:FLGT) and Grail (NASDAQ:GRAL)
Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Grail (NASDAQ:GRAL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Institutional & Insider Ownership 48.1% of Fulgent Genetics […] - 2025-05-12 02:54:58
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP reduced its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,045,815 shares of the company’s stock after selling 60,579 shares during the period. Dimensional Fund Advisors LP’s holdings in Fulgent Genetics were worth $19,316,000 as of its most recent […] - 2025-05-08 04:50:45
Barclays PLC Raises Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Barclays PLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 3.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 180,397 shares of the company’s stock after acquiring an additional 5,542 shares during the quarter. Barclays PLC’s holdings in Fulgent Genetics were worth $3,332,000 as of its most […] - 2025-04-29 05:18:59
Federated Hermes Inc. Buys 1,774 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
Federated Hermes Inc. lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 4.4% in the fourth quarter, HoldingsChannel reports. The fund owned 41,882 shares of the company’s stock after acquiring an additional 1,774 shares during the period. Federated Hermes Inc.’s holdings in Fulgent Genetics were worth $774,000 as of its […] - 2025-04-16 05:13:02
Piper Sandler Has Lowered Expectations for Fulgent Genetics (NASDAQ:FLGT) Stock Price
Fulgent Genetics (NASDAQ:FLGT – Get Free Report) had its price target cut by equities researchers at Piper Sandler from $22.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective suggests a potential downside of 3.90% from the stock’s current price. Separately, […] - 2025-03-06 05:27:14
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund cut its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 12.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,609 shares of the company’s stock after selling 1,324 shares during the quarter. Illinois Municipal Retirement […] - 2025-03-05 08:01:50
SG Americas Securities LLC Cuts Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
SG Americas Securities LLC cut its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 28.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,518 shares of the company’s stock after selling 4,934 shares during the quarter. SG Americas Securities LLC’s holdings in Fulgent Genetics were worth $231,000 as of its most […] - 2025-02-07 06:25:42
Exchange Traded Concepts LLC Has $652,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Exchange Traded Concepts LLC increased its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Free Report) by 5.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,324 shares of the company’s stock after acquiring an additional 1,689 shares […] - 2025-01-30 06:53:06

iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) FLGT holdings

DateNumber of FLGT Shares HeldBase Market Value of FLGT SharesLocal Market Value of FLGT SharesChange in FLGT Shares HeldChange in FLGT Base ValueCurrent Price per FLGT Share HeldPrevious Price per FLGT Share Held
2025-11-27 (Thursday)2,137USD 64,431USD 64,4310USD 0 USD 30.1502 USD 30.1502
2025-11-26 (Wednesday)2,137USD 64,431FLGT holding decreased by -1495USD 64,4310USD -1,495 USD 30.1502 USD 30.8498
2025-11-25 (Tuesday)2,137USD 65,926FLGT holding increased by 427USD 65,9260USD 427 USD 30.8498 USD 30.65
2025-11-24 (Monday)2,137USD 65,499FLGT holding increased by 1389USD 65,4990USD 1,389 USD 30.65 USD 30
2025-11-21 (Friday)2,137USD 64,110FLGT holding increased by 2607USD 64,1100USD 2,607 USD 30 USD 28.7801
2025-11-20 (Thursday)2,137USD 61,503FLGT holding decreased by -470USD 61,5030USD -470 USD 28.7801 USD 29
2025-11-19 (Wednesday)2,137USD 61,973FLGT holding decreased by -214USD 61,9730USD -214 USD 29 USD 29.1001
2025-11-18 (Tuesday)2,137USD 62,187FLGT holding increased by 620USD 62,1870USD 620 USD 29.1001 USD 28.81
2025-11-17 (Monday)2,137USD 61,567FLGT holding decreased by -620USD 61,5670USD -620 USD 28.81 USD 29.1001
2025-11-14 (Friday)2,137USD 62,187FLGT holding decreased by -1047USD 62,1870USD -1,047 USD 29.1001 USD 29.5901
2025-11-13 (Thursday)2,137USD 63,234FLGT holding increased by 1090USD 63,2340USD 1,090 USD 29.5901 USD 29.08
2025-11-12 (Wednesday)2,137USD 62,144FLGT holding increased by 1496USD 62,1440USD 1,496 USD 29.08 USD 28.38
2025-11-11 (Tuesday)2,137FLGT holding increased by 138USD 60,648FLGT holding increased by 6355USD 60,648138USD 6,355 USD 28.38 USD 27.1601
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of FLGT by for IE000T9EOCL3

Show aggregate share trades of FLGT

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-11BUY13828.81027.170 27.334USD 3,772 19.83
2025-09-25BUY27622.03022.400 22.363USD 6,172 19.04
2025-07-31BUY13917.18017.520 17.486USD 2,431 18.97
2025-06-17BUY13720.26020.890 20.827USD 2,853 18.91
2025-05-14BUY54819.66020.550 20.461USD 11,213 17.96
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of FLGT

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1916,927047,15535.9%
2025-09-1823,6841268,00334.8%
2025-09-1719,978051,34538.9%
2025-09-1619,250047,01240.9%
2025-09-1524,83712156,86043.7%
2025-09-1233,716059,81056.4%
2025-09-1154,523099,62354.7%
2025-09-1024,973064,24938.9%
2025-09-0916,659045,51336.6%
2025-09-0819,936054,22236.8%
2025-09-0517,579941,53442.3%
2025-09-0432,3469,68553,21660.8%
2025-09-0332,970056,68958.2%
2025-09-0238,6432778,15349.4%
2025-08-2927,3082,83968,76839.7%
2025-08-2827,754057,78148.0%
2025-08-2722,06712749,68044.4%
2025-08-2616,392029,28256.0%
2025-08-2515,1057544,52433.9%
2025-08-2216,377049,53733.1%
2025-08-218,982056,12216.0%
2025-08-2018,003034,26752.5%
2025-08-1917,0046439,01543.6%
2025-08-1819,8114452,18538.0%
2025-08-1521,6580105,49920.5%
2025-08-1422,0733955,15940.0%
2025-08-1322,148072,68230.5%
2025-08-1224,7723,61875,44732.8%
2025-08-1115,239065,20023.4%
2025-08-0812,880073,51417.5%
2025-08-0735,017151119,78829.2%
2025-08-0626,756095,46228.0%
2025-08-0585,52850374,31722.8%
2025-08-0497,24010,181180,68953.8%
2025-08-01184,1629,712343,99653.5%
2025-07-3164,2047127,84950.2%
2025-07-3053,9720100,31853.8%
2025-07-29136,0006,422168,95880.5%
2025-07-2832,455081,37639.9%
2025-07-2549,5897584,67458.6%
2025-07-2436,290087,96441.3%
2025-07-2363,9100147,58443.3%
2025-07-2253,392136103,09851.8%
2025-07-2134,58572880,39443.0%
2025-07-1847,47816091,26052.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.